Latest Loren Walensky Stories
Scientists at the Dana-Farber/Children's Hospital Cancer Center have developed an anti-cancer peptide that overcomes the stubborn resistance to chemotherapy and radiation often encountered in certain blood cancers when the disease recurs following initial treatment.
Scientists at Dana-Farber Cancer Institute have found a way to disable a common protein that often thwarts chemotherapy treatment of several major forms of cancer.
Aileron Therapeutics announced today that one of its proprietary Stapled Peptide compounds, referred to as "BIM-SAHB" in an article published today in Nature, was shown to uniquely target a new and fundamental activation mechanism of the programmed cell death or "apoptotic" pathway.
- An imitative word; an onomatopoetic word.